Amarin Corp Plcuk (AMRN) Enterprise Value (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Enterprise Value of -$177.0 million for Q1 2026, down 8.88% YoY from -$194.3 million in Q1 2025, and up 41.5% sequentially from -$302.6 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Enterprise Value (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Enterprise Value across 17 years of filings, most recently posting -$177.0 million for Q1 2026.

  • In Q1 2026, Enterprise Value fell 8.88% year-over-year to -$177.0 million; the TTM figure through Mar 2026 stood at -$177.0 million (down 8.88% YoY), while the FY2025 annual figure was -$302.6 million, down 74.42% from the prior year.
  • Enterprise Value grew to -$177.0 million in Q1 2026, from -$302.6 million in the prior quarter.
  • Over the last five years, Enterprise Value for AMRN reached as high as -$50.4 million in Q3 2023 and fell as low as -$362.6 million in Q1 2022.
  • The 5-year median for Enterprise Value is -$173.5 million (2024), against an average of -$198.7 million.
  • Annual changes were most pronounced in 2022 — Enterprise Value surged 85.99% — and 2024, when it slumped 506.86%.
  • A 5-year view of Enterprise Value shows it stood at -$92.2 million in 2022, then plunged by 32.22% to -$121.9 million in 2023, then sank by 42.28% to -$173.5 million in 2024, then slumped by 74.42% to -$302.6 million in 2025, then jumped by 41.5% to -$177.0 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$177.0 million, -$302.6 million, and -$164.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -5.28 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -22.05 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -9.35 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -7.89 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -5.65 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -12.04 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -7.73 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -12.77 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - 315.00 Mn
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn -177.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -177.00 Mn
Dec 31, 2025 -302.59 Mn
Sep 30, 2025 -164.10 Mn
Jun 30, 2025 -298.70 Mn
Mar 31, 2025 -162.56 Mn
Dec 31, 2024 -173.48 Mn
Sep 30, 2024 -305.69 Mn
Jun 30, 2024 -306.60 Mn
Mar 31, 2024 -94.76 Mn
Dec 31, 2023 -121.93 Mn
Sep 30, 2023 -50.37 Mn
Jun 30, 2023 -80.42 Mn
Mar 31, 2023 -304.37 Mn
Dec 31, 2022 -92.22 Mn
Sep 30, 2022 -67.12 Mn
Jun 30, 2022 -313.23 Mn
Mar 31, 2022 -362.61 Mn
Dec 31, 2021 -454.13 Mn
Sep 30, 2021 -479.20 Mn
Jun 30, 2021 -185.83 Mn